IMVT

IMVT

USD

Immunovant Inc. Common Stock

$24.190+0.810 (3.464%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$23.380

Hoch

$24.530

Tief

$23.310

Volumen

1.45M

Unternehmensfundamentaldaten

Marktkapitalisierung

4.2B

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.71M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $12.72Aktuell $24.190Hoch $32.1

Ähnliche Nachrichten

GlobeNewswire

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (NASDAQ:IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m.

Mehr anzeigen
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
Analyst Upgrades

Truist Securities Initiates Coverage On Immunovant with Hold Rating, Announces Price Target of $16

Truist Securities analyst Danielle Brill initiates coverage on Immunovant with a Hold rating and announces Price Target of $16.

Mehr anzeigen
Truist Securities Initiates Coverage On Immunovant with Hold Rating, Announces Price Target of $16

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.